http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17353417

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't
issn 1476-4598
issueIdentifier 1
pageRange 40-
publicationName Molecular Cancer
startingPage 40
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b8f22f810db2b41daebb5b9247c13aef
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e12e453dd5b492b0deb8cdf172297496
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_52065113c1fc6f2d2a1b43531dcafeb6
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c7ef8ab3e04806e55ba8d929f8469018
bibliographicCitation Yang DT, Young KH, Kahl BS, Markovina S, Miyamoto S. Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma. Molecular Cancer. 2008 May 19;7(1):40. doi: 10.1186/1476-4598-7-40.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5a1af1a1f7e8808ac68d004149ff24dc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bede2e1c5ffaeb8cae05e826210d6273
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2da567de73f2640bda9810fce6c782d0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a0afba696fc850441397564afc2a4183
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3c9e6a5aa57d1d34bb056e0d6b5f09c
date 2008-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/18489772
https://pubmed.ncbi.nlm.nih.gov/PMC2408930
https://doi.org/10.1186/1476-4598-7-40
isPartOf https://portal.issn.org/resource/ISSN/1476-4598
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/29835
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma
discusses http://id.nlm.nih.gov/mesh/M0024955
http://id.nlm.nih.gov/mesh/M0350110
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0018225
http://id.nlm.nih.gov/mesh/M0140424
http://id.nlm.nih.gov/mesh/M0002834
http://id.nlm.nih.gov/mesh/M0560885
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID387447
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10819
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_be31966c8b098b5f6c016d466992c413
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9e5ebec7b7c15968bb290a4683871c02
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a80abac7db6a718743ccfe8126ef5d1c
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.25.1
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8388
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243055978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129888650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128687728
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128255004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129467351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128141778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129709126
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127960150
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136137642
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127722233
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128397534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128364298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128902940
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128482492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129746213

Total number of triples: 65.